Global expansion Syneos Health is expanding offices in Pune, India, signaling growth in Asia and a potential need for local regulatory, clinical, and study management support services. This creates opportunities to offer site feasibility, regulatory consulting, and clinical operations solutions tailored to EU markets and CMC Module 3 activities.

Leadership bolstering Recent appointment of a new Chief Medical Officer and a Head of Global Project Delivery indicates a focus on advancing next-generation drug development and scalable delivery capabilities. Leverage for partnerships around early-phase to late-phase programs, medical strategy, and program efficiency enhancements.

Strategic partnerships Collaborations with Helio Genomics and AI-driven partners highlight a push toward AI-enabled insights and precision genomics. This opens doors for joint offerings in AI-powered trial design, patient stratification, and data analytics to improve trial outcomes and accelerate timelines.

Digital engagement wins Awards for Mobile App for Patient Engagement position Syneos Health as a leader in digital patient engagement. This presents upsell opportunities for end-to-end patient-centric solutions, mobile health apps, patient retention programs, and real-world data collection services.

Technology stack readiness Adoption of modern tech such as SvelteKit, OneTrust, and OWASP-aligned security implies readiness for secure, scalable digital platforms. Offer integrated technology-enabled trials, data privacy compliance solutions, and enterprise reporting capabilities to improve program management and regulatory readiness.